Pharmacogenomics: Identification of New Drug Targets
Principles of Pharmacogenetics: Types of Genetic Variants
Single Nucleotide Polymorphisms-SNPs
Comparing Copy Number Variations and SNPs
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenetics and Pharmacogenomics: Overview
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 27, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
M González-Castejón1, F Marín, C Soler-Rivas
1IMDEA Food Institute, CLAID-PCM Building, Campus de Cantoblanco Madrid 28049, Spain.
Non-synonymous single nucleotide polymorphisms (nsSNPs) cause protein changes, impacting disease risk. Identifying functional nsSNPs aids drug development by revealing precise therapeutic targets and understanding genetic disease links.
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: